First Month on GLP-1 (2026): 2-5 lbs Lost Week 1-4, Nausea Peaks Week 4, Week-by-Week

Verified April 2026: GLP-1 patients lose 2-5 pounds in their first month on medication, with noticeable appetite suppression starting within 1-2 weeks. Nausea peaks during the first dose escalation at week 4, but 98.1% of GI side effects in the STEP-1 and SURMOUNT-1 trials were classified as mild-to-moderate. The standard starting dose is 0.25mg/week semaglutide (Wegovy) or 2.5mg/week tirzepatide (Zepbound), both escalate every 4 weeks for the first 16-20 weeks.

Quick answer by week:

• •Week 1: Starter dose injected, mild nausea 24-48 hours after, subtle appetite reduction. 0-2 lbs lost.
• •Week 2-3: Appetite suppression settles in, meal portions naturally shrink. 1-3 lbs lost.
• •Week 4: First dose escalation (0.25mg → 0.5mg sema, or 2.5mg → 5mg tirz). Nausea may return briefly. Total first-month loss: 2-5 lbs.
• •Week 5+: See dosing timeline tool for your full 20-week escalation map.

This guide covers the complete first-month timeline, consultation, injection technique, side effect management, and week-by-week expectations, based on FDA prescribing info and published trial data. Before you start, use our match quiz to find the best provider, or check the GLP-1 side effects management guide for what to do if nausea becomes severe.

Before You Start: The Consultation

Most telehealth platforms follow a similar process. You'll complete a medical questionnaire covering your weight history, current medications, medical conditions, and goals. A licensed provider reviews your information, usually within 24-48 hours, and determines if you're a candidate.

Some platforms require lab work (metabolic panel, thyroid function) before prescribing. Others include labs as part of the program. Your provider will choose a starting dose, all GLP-1s begin at a low dose to minimize side effects.

Week 1: Starting Dose

You'll start at the lowest available dose. Per the Wegovy prescribing information, injectable semaglutide starts at 0.25mg once weekly. For tirzepatide (Zepbound), it's 2.5mg once weekly.

• •Appetite changes may be subtle or noticeable, everyone responds differently
• •Some people notice reduced food cravings within the first few days
• •Mild nausea is common, especially in the first 24-48 hours after injection
• •You may feel fuller faster during meals
• •Weight loss in week 1 is usually minimal, don't expect dramatic changes yet

Weeks 2-3: Settling In

By your second and third weeks, your body is adjusting. This is when most people start noticing meaningful appetite reduction. You may find yourself eating smaller portions without trying, or losing interest in snacking between meals.

GI side effects, if you have them, are usually at their mildest on the starting dose. The most common are mild nausea (often around meal times), changes in bowel habits, and occasional bloating. Staying hydrated and eating smaller, more frequent meals helps.

Week 4: First Dose Escalation

After 4 weeks on the starting dose, most protocols escalate to the next level. For semaglutide, that's 0.5mg; for tirzepatide, 5mg. This is when side effects tend to be most noticeable, your body is adjusting to a higher dose.

• •Nausea may return or increase for the first few days at the new dose
• •Appetite suppression typically becomes more pronounced
• •Most people see their first meaningful weight loss (2-5 lbs) by end of month 1
• •Energy levels may fluctuate as your caloric intake naturally decreases
• •Side effects at each new dose level typically peak in the first week then improve

It takes several months of gradual dose escalation to reach the target maintenance dose. Semaglutide takes about 16-20 weeks to reach 2.4mg; tirzepatide takes 16-28 weeks to reach 10-15mg. Don't rush this, the slow escalation is specifically designed to improve tolerability. In clinical trials, 98.1% of GI side effects were mild-to-moderate.

How Much Weight Will You Lose in the First Month?

The clinical trial averages are achieved over 68-72 weeks, not overnight. A realistic timeline:

• •Month 1: 1-3% body weight loss (mostly from reduced food intake)
• •Months 2-4: Weight loss accelerates as doses increase, roughly 1-2% per month
• •Months 4-12: Continued steady loss as you reach maintenance dose
• •Month 12-16: Most patients reach their maximum weight loss on the medication
• •Beyond 16 months: Weight maintenance phase, studies show weight stays off as long as you continue the medication